Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Healius Limited (DE:PGZ – Research Report), Cipher Pharmaceuticals (CPHRF – Research Report) and AstraZeneca (GB:AZN – Research Report).
Healius Limited (DE:PGZ)
Morgan Stanley analyst Sean Laaman maintained a Sell rating on Healius Limited yesterday and set a price target of A$1.30. The company’s shares closed yesterday at EUR0.85.
According to TipRanks.com, Laaman is a 3-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Healius Limited with an EUR0.99 average price target.
See today’s best-performing stocks on TipRanks >>
AstraZeneca (GB:AZN)
In a report released yesterday, Sachin Jain from Bank of America Securities maintained a Buy rating on AstraZeneca, with a price target of p14500.00. The company’s shares closed last Thursday at p9725.00, close to its 52-week high of p10120.00.
Jain has an average return of
According to TipRanks.com, Jain is ranked #2152 out of 8720 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for AstraZeneca with a p10772.00 average price target, representing a 10.7% upside. In a report issued on January 30, Barclays also maintained a Buy rating on the stock with a £135.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
